TY - JOUR
T1 - Roche defends buying lavish meals for doctors at Sydney's restaurants
AU - Moynihan, Ray
PY - 2006/7/20
Y1 - 2006/7/20
N2 - The dinners were part of a Roche sponsored scientific symposium on haematology-oncology treatments, which included the company's top selling pharmaceutical, rituximab (MabThera), which has annual sales of more than SFr4bn (£1.8bn; €2.6bn; $3.2bn).
AB - The dinners were part of a Roche sponsored scientific symposium on haematology-oncology treatments, which included the company's top selling pharmaceutical, rituximab (MabThera), which has annual sales of more than SFr4bn (£1.8bn; €2.6bn; $3.2bn).
UR - http://www.scopus.com/inward/record.url?scp=33746297403&partnerID=8YFLogxK
U2 - 10.1136/bmj.333.7560.169
DO - 10.1136/bmj.333.7560.169
M3 - Article
C2 - 16858041
AN - SCOPUS:33746297403
SN - 0959-535X
VL - 333
SP - 169
EP - 169
JO - BMJ (Clinical research ed.)
JF - BMJ (Clinical research ed.)
IS - 7560
ER -